Clinical Trial Update: Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing S-1 for 6 months to 1 year as adjuvant chemotherapy after D2 gastrectomy in gastric cancer (stages II, IIIA, IIIB) has been wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Fudan University | Conditions: Gastric Cancer | Phase 3 | Status: WITHDRAWN